News

Pfizer has reported a net income of $2.73 billion, or $0.40 diluted earnings per share for the first quarter of 2009, a decline of 2%, compared to $2.78

Accordingly the company is no longer relying on the previously announced R&D test data and results. Sequenom has not changed its plans to develop in parallel its RNA-

Portuguese pharmaceutical company Bial-Portela & CA, and Eisai Europe Limited, the European subsidiary of Eisai Co, have reported that the novel once daily anti-epileptic Zebinix has received marketing

This design will enable patients to mix and administer exenatide once weekly from a pre-filled pen device, instead of the syringe and vial currently used in clinical trials,

PerClot Laparoscopic, a delivery configuration within the PerClot polysaccharide hemostatic system, was awarded CE approval in 2008. Perclot laparoscopic is a hemostatic system designed for applications in minimally

Walt Woltosz, chairman and CEO of Simulations Plus, said: “DDDPlus remains the only program of its kind in the world today. DDDPlus saves time and money. Rather than

Under this agreement, AMRI will test samples from its compound collection against several JNK kinases. These kinases may be implicated in the progression of Huntington’s disease (HD). AMRI

According to Medical Nutrition USA, the product, which is an enhanced formulation of Pro-Stat AWC, is designed for patients in long-term care facilities with advanced wounds, primarily pressure

According to United Therapeutics, the appointment of Mr Giltner brings the total number of directors to nine, six of whom are independent and not affiliated with the company.